Literature DB >> 9710520

MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose.

M E Emborg-Knott1, E F Domino.   

Abstract

Five female adult Macaca nemestrina monkeys, given a unilateral intracarotid (ic) infusion of 2.3-3.5 mg of MPTP-HCl, were studied for 6-8 years. Two to 3 days after MPTP, the animals developed hemiparkinsonism characterized by rigidity and flexed posture of the arm contralateral to the side of infusion with episodes of tremor, circling ipsilateral to the lesioned side, a slight balance disturbance, and stooped posture. Rating of parkinsonian features 4 months after ic infusion, and yearly thereafter, did not show any statistically significant changes. The animals maintained their usual appetite and body weight increased normally. Each animal responded to l-DOPA methyl ester with decreased parkinsonian signs and symptoms and increased contralateral turning. In contrast, after control vehicle administration, the animals continued to have the same parkinsonian signs and predominant ipsilateral turns. In three of the five monkeys, contralateral turns after vehicle significantly increased after 6-8 years. Unilateral intracarotid MPTP induced asymmetric motor behavior that remained stable after 6-8 years. Animals that showed an increased frequency of contralateral circling after control vehicle showed a decrease in contralateral turns after l-DOPA methyl ester, suggesting neuroplastic changes over the years. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710520     DOI: 10.1006/exnr.1998.6845

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF.

Authors:  M E Emborg; J Moirano; J Raschke; V Bondarenko; R Zufferey; S Peng; A D Ebert; V Joers; B Roitberg; J E Holden; J Koprich; J Lipton; J H Kordower; P Aebischer
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

Review 2.  Mood, memory and movement: an age-related neurodegenerative complex?

Authors:  Ann-Charlotte Granholm; Heather Boger; Marina E Emborg
Journal:  Curr Aging Sci       Date:  2008-07

3.  The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias.

Authors:  Vishakh Iyer; Kala Venkiteswaran; Sandip Savaliya; Christopher A Lieu; Erin Handly; Timothy P Gilmour; Allen R Kunselman; Thyagarajan Subramanian
Journal:  Neurobiol Dis       Date:  2021-08-27       Impact factor: 5.996

4.  Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys.

Authors:  Marina E Emborg; Zhijian Zhang; Valerie Joers; Kevin Brunner; Viktorya Bondarenko; Sachiko Ohshima; Su-Chun Zhang
Journal:  Cell Transplant       Date:  2013       Impact factor: 4.064

5.  Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates.

Authors:  Christine Swanson; Marina Emborg
Journal:  Neurol Res       Date:  2013-12-27       Impact factor: 2.448

6.  The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys.

Authors:  Christine R Swanson; Valerie Joers; Viktoriya Bondarenko; Kevin Brunner; Heather A Simmons; Toni E Ziegler; Joseph W Kemnitz; Jeffrey A Johnson; Marina E Emborg
Journal:  J Neuroinflammation       Date:  2011-08-05       Impact factor: 8.322

7.  A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys.

Authors:  Sachiko Ohshima-Hosoyama; Heather A Simmons; Nichole Goecks; Valerie Joers; Christine R Swanson; Viktoriya Bondarenko; Rebecca Velotta; Kevin Brunner; Laura D Wood; Ralph H Hruban; Marina E Emborg
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.